Related Experiment Video
Updated: Aug 21, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Nutrition in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Dieudonne Nonga1, Jonathan Gisser1, Eileen Chaves2
1Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA, osu.edu.
None:
Lifestyle change, including weight loss in children with overweight and obesity, through intensive health behavior and lifestyle treatment (IHBLT) is one of the main pillars in the management of pediatric metabolic dysfunction-associated steatotic liver disease (MASLD). Approximately 10% of school-aged children in the United States-and an even higher percentage of children with obesity-are affected by MASLD. The stigma, combined with peer and society pressure to maintain a "healthy" weight, as it pertains to MASLD, has led a percentage of affected children to adapt restrictive patterns of eating that have culminated in malnutrition, nutrient deficiencies, disordered eating, anxiety and mood, and eating disorders. Prompt recognition through screening and targeted interventions is needed to address this crisis. Our paper offers a concise review and approach to the nutrition evaluation and assessment of malnutrition and nutrition deficiencies in children with pediatric obesity and MASLD and addresses interventions considered to mitigate this health outcome. We reviewed the literature pertaining to pediatric MASLD and malnutrition, nutrient deficiencies, eating behaviors, eating disorders, disordered eating, and food insecurity in the pediatric population. We focused on the evaluation, assessment, and management of malnutrition and nutrition and behavioral interventions recommended in pediatric MASLD. Overall, IHBLT alone has not been sufficient to curb the pediatric obesity and MASLD epidemic, and there has been a growing interest in specific pediatric MASLD pharmacotherapies and their related nutritional and behavioral side effects. Ultimately, assessing and addressing nutrient deficiencies, mood disturbances, and disordered eating behaviors is critical to mitigating the long-term consequences of this disease, while improving food access and distribution can further optimize metabolic health outcomes through high-quality nutrition.
Related Concept Videos
Inborn Errors of Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
